Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Curis Inc (NASDAQ: CRIS)

$2.53 USD -$0.14 (-5.24%)
Last Price $2.53
Net Change $-0.14 (-5.24%)
Bid $2.48
Ask Price $2.9
Open Price $2.66
Previous Close Price $2.67
High Price $2.67
Low Price $2.52
Number of Trades 1,594
Volume 468,600
Fifty Two Week High $3.72 (2016-11-15)
Fifty Two Week Low $1.47 (2016-06-27)
Average Daily Volume 510,836
Share Outstanding 143,200 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.08 (2017-03-09)
2nd Quarter Earnings $-0.21 (2016-11-03)
3nd Quarter Earnings $-0.09 (2016-08-04)
4th Quarter Earnings $-0.07 (2016-05-09)
PE Ratio $0
EPS Growth $-8.33
Recent Earnings $-0.08
Annual EPS $-0.36
Last Quarter EPS $
Market Capitalization $0.36B
Insider Shareholders % 0.0609%
Annual Revenue $0B
No. Shares Outstanding 143,200
Inst. Shareholder % 50.41%
Annual Net Income $0B
TTM Net Profit Margin $100.57
1-Year Return 13.45%
3-Year Return 9.52%
5-Year Return -47.29%
5-Year Revenue Growth -48.98%
5-Year Earnings Growth 176.92%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -8.33%
Dividends per Share $
Stock Split Ratio
Beta 1.8
Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.

CRIS News & Stock Updates